On October 29, 2015, Privacy Analytics held a side event at the 37th International Privacy Conference in Amsterdam, The Netherlands. This event, The Anonymization of Clinical Trial Data in Practice, featured key industry experts, including:
- Jean-Marc Ferran, PhUSE
- Monica Diaz, European Medicines Agency
- Pierre-Yves Lastic, Sanofi
- Jean-Marc Ferran, PhUSE
- Stephen Korte, Privacy Analytics
- Khaled El Emam, Privacy Analytics
There is an influx of clinical trial data being shared by pharmaceutical companies for secondary analysis. Of course, sharing this sensitive data requires that it be de-identified first beforehand. There have been a number of de-identification standards and guidelines published over the last year that address sharing clinical trial data, such as the Institute of Medicine report, Sharing Clinical Trial Data: Maximizing Benefit Minimizing Risk, as well as guidelines from HITRUST, PhUSE and TransCelerate.
The Anonymization of Clinical Trial Data in Practice session emerges in the wake of these new guidelines, as the European Medicines Agency works on developing general anonymization guidance that is consistent with EU laws. The purpose of this session was to learn from these initial experiences in the wake of these new standards and discuss their impact. Not only was there discussion around standards and regulations, but on how to use risk-based de-identification tools to minimize risk, automate the process and scale to the size of databases.
Included in this session were presentations that discussed EMA Policy 0070, Sanofi’s De-Identification Process, a case study on the de-identification of individual patient data (IPD), and Anonymizing CSRs.
If you would like to get a glimpse into these presentations, please click on the links above.
Interested in learning more about de-identifying clinical trial data? Join us January 21-22, 2016 in NYC. We are hosting a 2-day comprehensive training course on the subject. You can register here.
The post Anonymizing Clinical Trial Data in Practice appeared first on Privacy Analytics.